Transition report pursuant to Rule 13a-10 or 15d-10

Significant Transactions (Details Textual)

v3.21.1
Significant Transactions (Details Textual) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Jul. 07, 2020
Jan. 30, 2020
Jan. 15, 2020
Jun. 30, 2020
Jun. 30, 2020
Dec. 31, 2020
Dec. 31, 2019
Jun. 30, 2020
Jun. 30, 2019
Sep. 01, 2020
Jul. 31, 2020
Apr. 08, 2020
Business Acquisition [Line Items]                        
Common stock, shares issued     1,950,000 13,258,707 13,258,707 19,901,248   13,258,707 10,589,746   800,000  
Convertible into shares of common stock per share     $ 9.00                  
Percentage of exchange rate       55.00% 55.00%     55.00%        
Description of contingent consideration               (i) $0.01 per solo*TAG™ and solo*CODE™ sold or (ii) 7% of net revenue. The fees were to be paid annually until the earlier of: (1) our shares trading above $12 per share for any consecutive 20 trading days in a 30-day period; (b) upon our no longer owning a majority stake in Solo; or (c) upon expiration of the patents related to solo*TAG™ and solo*CODE™, which is December 1, 2029.        
Amortization expense of intangible assets           $ 1,800,000   $ 1,300,000        
Revenues           7,824,784 $ 6,499,093 12,573,276 $ 10,823,117      
Net loss           $ (16,957,334) $ (6,090,027) $ (15,534,345) $ (12,403,215)      
Preferred stock, par value       $ 0.0001 $ 0.0001 $ 0.0001   $ 0.0001 $ 0.0001      
Preferred stock, liquidation preference per share           $ 1.00            
Exchangeable shares                   627,225    
Exchangeable shares issued           2,667,349       4,798,271    
Assets and liability acquired           $ 14,300            
General and administrative expenses       $ 1.8   1.1            
Trellis Solutions, Inc [Member]                        
Business Acquisition [Line Items]                        
Transaction costs                       $ 100,000
Common stock, shares issued                       349,650
Convertible into shares of common stock per share                       $ 7.24
Percentage of exchange rate                       100.00%
Amount of contingent consideration liability                       $ 1.0
Revenues         $ 216,000              
Net loss         $ 17,000              
Solo Sciences, Inc. [Member]                        
Business Acquisition [Line Items]                        
Transaction costs     $ 300,000                  
Percentage of exchange rate     80.40% 40.00% 40.00%     40.00%        
Estimated of fair value contingent consideration     $ 17,900,000                  
Revenues   $ 23,000                    
Net loss   $ 1,471,000                    
Ample Organics [Member]                        
Business Acquisition [Line Items]                        
Transaction costs           2,900,000            
Revenues           2.6            
Net loss           $ 0.1            
Acquisition of description acquired 100% of the stock of Ample Organics for 3.3 million exchangeable shares of one of our wholly-owned subsidiaries. The exchangeable shares may be exchanged, at the option of the holder, for shares of Akerna common stock on a one-for-one basis, therefore the exchangeable shares issued were valued at $7.65 per share, the closing price of an equivalent share of Akerna common stock, $30.7 million was the aggregate value of the exchangeable shares. In addition to the stock consideration, we paid $5.5 million in cash, which was used to settle all of Ample's then outstanding debt. In addition to the stock and cash consideration, the agreement provides for contingent consideration of up to CAD$10,000,000, payable in exchangeable shares, payable if Ample's Recurring Revenue recognized during the 12 months after the acquisition date is CAD$9,000,000 or more. The contingent consideration amount is reduced by an amount equal to the product of CAD$6.67 multiplied by the difference between CAD$9,000,000 and the amount of Recurring Revenue realized during the 12 months following the acquisition.